Answers are grounded in this paper and cite their sources.
The management of patients with NMIBC is responsible for a substantial financial burden with indirect costs that extend beyond quantifiable direct costs.
No takes yet. Share an insight, caveat, or question.
Mossanen et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: